These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20683000)

  • 1. Overexpression of MMP-13 gene in colorectal cancer with liver metastasis.
    Yamada T; Oshima T; Yoshihara K; Tamura S; Kanazawa A; Inagaki D; Yamamoto N; Sato T; Fujii S; Numata K; Kunisaki C; Shiozawa M; Morinaga S; Akaike M; Rino Y; Tanaka K; Masuda M; Imada T
    Anticancer Res; 2010 Jul; 30(7):2693-9. PubMed ID: 20683000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Kunisaki C; Yoshihara K; Yamada R; Yamamoto N; Sato T; Makino H; Yamagishi S; Nagano Y; Fujii S; Shiozawa M; Akaike M; Wada N; Rino Y; Masuda M; Tanaka K; Imada T
    Oncol Rep; 2008 May; 19(5):1285-91. PubMed ID: 18425389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
    Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R
    Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of the expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA tissue samples from colorectal liver metastases.
    Sutnar A; Pesta M; Liska V; Treska V; Skalicky T; Kormunda S; Topolcan O; Cerny R; Holubec L
    Tumour Biol; 2007; 28(5):247-52. PubMed ID: 17992052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.
    Zeng ZS; Guillem JG
    Br J Cancer; 1995 Sep; 72(3):575-82. PubMed ID: 7669564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasion front-specific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer.
    Kahlert C; Bandapalli OR; Schirmacher P; Weitz J; Brand K
    Anticancer Res; 2008; 28(3A):1459-65. PubMed ID: 18630499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity.
    Ishizaki T; Katsumata K; Tsuchida A; Wada T; Mori Y; Hisada M; Kawakita H; Aoki T
    Int J Mol Med; 2006 Feb; 17(2):357-62. PubMed ID: 16391837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.
    Pesta M; Topolcan O; Holubec L; Rupert K; Cerna M; Holubec LS; Treska V; Finek J; Cerny R
    Anticancer Res; 2007; 27(4A):1863-7. PubMed ID: 17649785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of tissue inhibitor of metalloproteinase-1 gene correlates with poor outcomes in colorectal cancer.
    Inagaki D; Oshima T; Yoshihara K; Tamura S; Kanazawa A; Yamada T; Yamamoto N; Sato T; Shiozawa M; Morinaga S; Akaike M; Fujii S; Numata K; Kunisaki C; Rino Y; Tanaka K; Masuda M; Imada T
    Anticancer Res; 2010 Oct; 30(10):4127-30. PubMed ID: 21036730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Behavior of MMP-2, MMP-7, MMP-9, and Their Inhibitors TIMP-1 and TIMP-2 in Adenoma-Colorectal Cancer Sequence.
    Barabás L; Hritz I; István G; Tulassay Z; Herszényi L
    Dig Dis; 2021; 39(3):217-224. PubMed ID: 32961536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of MT1-MMP gene expression to outcomes in colorectal cancer.
    Kanazawa A; Oshima T; Yoshihara K; Tamura S; Yamada T; Inagaki D; Sato T; Yamamoto N; Shiozawa M; Morinaga S; Akaike M; Kunisaki C; Tanaka K; Masuda M; Imada T
    J Surg Oncol; 2010 Nov; 102(6):571-5. PubMed ID: 20721961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases.
    Zeng ZS; Cohen AM; Zhang ZF; Stetler-Stevenson W; Guillem JG
    Clin Cancer Res; 1995 Aug; 1(8):899-906. PubMed ID: 9816060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue inhibitor of matrix metalloproteinase-1 expression in colorectal cancer liver metastases is associated with vascular structures.
    Illemann M; Eefsen RH; Bird NC; Majeed A; Osterlind K; Laerum OD; Alpízar-Alpízar W; Lund IK; Høyer-Hansen G
    Mol Carcinog; 2016 Feb; 55(2):193-208. PubMed ID: 25594187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 expression by tumor cells implicated in liver metastasis from colorectal carcinoma.
    Ogata Y; Miura K; Ohkita A; Nagase H; Shirouzu K
    Kurume Med J; 2001; 48(3):211-8. PubMed ID: 11680936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.
    Zhang M; Teng XD; Guo XX; Li ZG; Han JG; Yao L
    Breast; 2013 Jun; 22(3):330-4. PubMed ID: 22995648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMP-10, MMP-7, TIMP-1 and TIMP-2 mRNA expression in esophageal cancer.
    Juchniewicz A; Kowalczuk O; Milewski R; Laudański W; Dzięgielewski P; Kozłowski M; Nikliński J
    Acta Biochim Pol; 2017; 64(2):295-299. PubMed ID: 28510611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors.
    Murashige M; Miyahara M; Shiraishi N; Saito T; Kohno K; Kobayashi M
    Jpn J Clin Oncol; 1996 Oct; 26(5):303-9. PubMed ID: 8895669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases.
    Zeng ZS; Shu WP; Cohen AM; Guillem JG
    Clin Cancer Res; 2002 Jan; 8(1):144-8. PubMed ID: 11801551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.